Garland Greg C. Acquires 665 Shares of Amgen Inc. Common Stock

Greg C. Garland, a director at Amgen Inc., acquired 665 shares of the company's common stock on May 19, 2026. The shares were acquired at a price of $0.0 per share, with a post-transaction total of 13848 shares. These shares were granted as Restricted Stock Units (RSUs) under the Amgen Inc. 2009 Director Incentive Program and vested immediately. The vested RSUs are paid in shares of common stock on a one-to-one basis and may be deferred by the director according to an elected schedule. This transaction is classified as direct ownership.